Esperion Therapeutics, Inc. short interest in 2023
In 2023, Esperion Therapeutics, Inc.'s disclosed short interest ran from 24.59% of shares outstanding on 13 Jan 2023 to 17.52% on 29 Dec 2023, a change of -7.07 percentage points. The year's high was 25.58% on 31 Jan 2023 and its low 12.53% on 31 Jul 2023, averaging 17.66% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.09 days on 31 Jan 2023. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 24.59% (13 Jan 2023)
- End of year
- 17.52% (29 Dec 2023)
- Change
- -7.07 pp
- High
- 25.58% (31 Jan 2023)
- Low
- 12.53% (31 Jul 2023)
- Average
- 17.66%
- Highest days to cover
- 19.09 (31 Jan 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 24.59% | 10.26 | results (8-K) |
| 31 Jan 2023 | 25.58% | 19.09 | |
| 15 Feb 2023 | 21.50% | 10.54 | |
| 28 Feb 2023 | 22.53% | 7.26 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 24.39% | 3.80 | |
| 31 Mar 2023 | 19.54% | 1.51 | |
| 14 Apr 2023 | 20.13% | 5.65 | |
| 28 Apr 2023 | 20.45% | 7.22 | |
| 15 May 2023 | 15.42% | 7.51 | 10-Q filed, results (8-K) |
| 31 May 2023 | 14.12% | 7.63 | |
| 15 Jun 2023 | 14.65% | 4.61 | |
| 30 Jun 2023 | 13.21% | 3.47 | |
| 14 Jul 2023 | 13.76% | 6.41 | |
| 31 Jul 2023 | 12.53% | 6.94 | |
| 15 Aug 2023 | 13.08% | 3.75 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 14.19% | 3.93 | |
| 15 Sep 2023 | 15.38% | 4.83 | |
| 29 Sep 2023 | 18.52% | 3.39 | |
| 13 Oct 2023 | 17.96% | 5.17 | |
| 31 Oct 2023 | 17.03% | 5.26 | |
| 15 Nov 2023 | 16.10% | 5.64 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 15.60% | 5.52 | |
| 15 Dec 2023 | 16.04% | 3.09 | |
| 29 Dec 2023 | 17.52% | 2.83 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.